济南龟头包皮特别的痒(济南男性射精不远怎么办) (今日更新中)

The Trump administration has announced that most individuals and businesses will be allowed to delay paying their federal tax bills for 90 days as part of an emergency relief plan amid the coronavirus pandemic.Some questions and answers about the delay and its potential impact on the U.S. economy.___DO I STILL NEED TO FILE?Yes.The details on the program are still scant. But as of now, taxpayers need to file their federal tax returns by the traditional April 15 deadline. The 90-day extension is solely for the money that is due. Those delayed payments are now due July 15.However, taxpayers who are facing difficulty filing on time always still have the option to request a six-month extension. Visit the IRS 725

The third and final supermoon of 2019 is set to be seen on Wednesday, just ahead of the official start of spring in the U.S.The next supermoon won't rise again until Feb. 9, 2020, 192

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

The Trump administration took hesitant first steps Wednesday to allow the importation of certain drugs from Canada and other countries.The historic move comes after President Donald Trump cast aside typical GOP opposition and pushed his health officials to find a way to approve the Republican governor of Florida's recent request to allow the importation of lower-cost drugs.The Department of Health & Human Services, which has long raised safety concerns over importation, released a Safe Drug Importation Plan that describes two ways certain drugs from abroad could enter the US. It marks a major turnaround for HHS Secretary Alex Azar, who called importation a "gimmick" in the past.But it will likely take a while before these lower-priced medications find their way into patients' hands.Under one scenario, states, pharmacists or drug wholesalers could submit plans to the agency for test projects on how they would import drugs approved by Health Canada. But the method also sets up many hurdles, including saying the tests would be limited in time and require regular reporting to ensure safety and costs are being met.The second pathway would allow manufacturers to import lower-cost versions of the drugs that they sell in foreign countries. Agency officials said drug makers are interested in doing this but have not been able to because of contracts with other players in the supply chain.Under the new plan, Insulin, however, cannot be imported from Canada, likely disappointing diabetics, some of whom have to travel north to purchase the costly, lifesaving medicine there.But HHS clearly put the burden on states and manufacturers to convince it that importing drugs would be safe for consumers and save them money. For instance, it would be up to states to negotiate with Canadian authorities to allow their drugs to be sent to the US, said Azar. 1878

The Transportation Security Administration (TSA) screened fewer passengers Monday than it had in the past 10 years, a spokesperson says.According to TSA public affairs spokesperson Lisa Farbstein, department officers screened 154,080 people at checkpoints across the country on Monday. On the same date in 2019, TSA screened 2.3 million people.The numbers highlight just how badly the coronavirus pandemic has crippled the airline industry. Three of the U.S.' largest airliners — 492

来源：资阳报